-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, and F45 Training and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Veru Provides Update on FDA Advisory Committee Meeting Regarding Emergency Use Authorization of Sabizabulin to Treat Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
-
-
-
-
-
-
-
Veru, Inc. (VERU) Confirms FDA has Updated Meeting Date for Advisory Committee Meeting to Review EUA for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS
-
-
-
-
-
-
15,627 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

